Unknown

Dataset Information

CRIP1 involves the pathogenesis of multiple myeloma via dual-regulation of proteasome and autophagy.


ABSTRACT:

Background

Multiple myeloma (MM) is an incurable hematological malignancy of the plasma cells. The maintenance of protein homeostasis is critical for MM cell survival. Elevated levels of paraproteins in MM cells are cleared by proteasomes or lysosomes, which are independent but inter-connected with each other. Proteasome inhibitors (PIs) work as a backbone agent and successfully improved the outcome of patients; however, the increasing activity of autophagy suppresses the sensitivity to PIs treatment.

Methods

The transcription levels of CRIP1 were explored in plasma cells obtained from healthy donors, patients with newly diagnosed multiple myeloma (NDMM), and relapsed/refractory multiple myeloma (RRMM) using Gene expression omnibus datasets. Doxycycline-inducible CRIP1-shRNA

SUBMITTER: Tang P 

PROVIDER: S-EPMC10825369 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature